Literature DB >> 12369875

HIV protease inhibitors: peptidomimetic drugs and future perspectives.

Hamdy M Abdel-Rahman1, Gamal S Al-karamany, Nawal A El-Koussi, Adel F Youssef, Yoshiaki Kiso.   

Abstract

A literature review on the human immunodeficiency virus (HIV), the causative agent of acquired immune deficiency syndrome (AIDS). This review includes its life cycle, HIV protease structure, function, and substrates, as well as the mechanism and the design of inhibitors including the clinically approved drugs. Moreover the review mentioned the problems that hindered the development of peptidomimetic drug candidates as HIV protease inhibitors and the different approaches used by medicinal chemists to overcome these problems. A special attention was made to the design rationale as well as the lead optimization processes that provided inhibitors that possess high potency, reduced molecular weight and lower lipophilicity of the allophenylnorstatine (Apns) containing HIV protease inhibitors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12369875     DOI: 10.2174/0929867023368890

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  10 in total

1.  Gated binding of ligands to HIV-1 protease: Brownian dynamics simulations in a coarse-grained model.

Authors:  Chia-En Chang; Tongye Shen; Joanna Trylska; Valentina Tozzini; J Andrew McCammon
Journal:  Biophys J       Date:  2006-03-13       Impact factor: 4.033

2.  Catalytic enantioselective hetero-Diels-Alder reactions of an azo compound.

Authors:  Masanori Kawasaki; Hisashi Yamamoto
Journal:  J Am Chem Soc       Date:  2006-12-27       Impact factor: 15.419

Review 3.  Fragment screening and HIV therapeutics.

Authors:  Joseph D Bauman; Disha Patel; Eddy Arnold
Journal:  Top Curr Chem       Date:  2012

4.  Discovery of potent beta-secretase (bace-1) inhibitors by the synthesis of isophthalamide-containing hybrids.

Authors:  Yi-Ping Zhu; Kun Xiao; Hai-Ping Yu; Lan-Ping Ma; Bing Xiong; Hai-Yan Zhang; Xin Wang; Jing-Ya Li; Jia Li; Jing-Kang Shen
Journal:  Acta Pharmacol Sin       Date:  2009-01-26       Impact factor: 6.150

5.  Targeting human immunodeficiency virus type 1 assembly, maturation and budding.

Authors:  Johanna Wapling; Seema Srivastava; Miranda Shehu-Xhilaga; Gilda Tachedjian
Journal:  Drug Target Insights       Date:  2007-07-20

6.  Synthesis, characterization, anti-inflammatory and in vitro antimicrobial activity of some novel alkyl/aryl substituted tertiary alcohols.

Authors:  Muhammad Baseer; Farzana Latif Ansari; Zaman Ashraf; Rafiuzzaman SaeedulHaq
Journal:  Molecules       Date:  2011-12-14       Impact factor: 4.411

7.  Enantioselective Copper-Catalyzed Cyanation of Remote C(sp3)-H Bonds Enabled by 1,5-Hydrogen Atom Transfer.

Authors:  Cheng-Yu Wang; Zi-Yang Qin; Yu-Ling Huang; Ruo-Xing Jin; Quan Lan; Xi-Sheng Wang
Journal:  iScience       Date:  2019-10-26

Review 8.  The role of medical structural genomics in discovering new drugs for infectious diseases.

Authors:  Wesley C Van Voorhis; Wim G J Hol; Peter J Myler; Lance J Stewart
Journal:  PLoS Comput Biol       Date:  2009-10-26       Impact factor: 4.475

9.  Microbial proteinase inside human cells as anti-mitochondrial activity: a new virulence factor in infectious diseases?

Authors:  Ger P A Bongaerts; Lambert P van den Heuvel
Journal:  Med Hypotheses       Date:  2007-09-07       Impact factor: 1.538

Review 10.  Antiviral Agents against Flavivirus Protease: Prospect and Future Direction.

Authors:  Subodh K Samrat; Jimin Xu; Zhong Li; Jia Zhou; Hongmin Li
Journal:  Pathogens       Date:  2022-02-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.